TransMedics (TMDX) Shares Outstanding (Diluted Average) (2020 - 2024)

TransMedics' Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $35.2 million for Q3 2024.

• In Q3 2024, Shares Outstanding (Diluted Average) rose 7.99% year-over-year to $35.2 million; the TTM figure through Sep 2024 stood at $35.2 million (up 7.99% YoY), while the FY2023 annual figure was $32.5 million, up 10.02% from the prior year.
• Shares Outstanding (Diluted Average) was $35.2 million for Q3 2024 at TransMedics, up from $35.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $35.2 million in Q3 2024 to a low of $21.2 million in Q1 2020.
• Historically, Shares Outstanding (Diluted Average) has averaged $29.0 million across 5 years, with a median of $28.0 million in 2022.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Diluted Average) increased 28.96% in 2021, then climbed 1.25% in 2022.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $24.7 million in 2020, then rose by 11.8% to $27.6 million in 2021, then grew by 7.02% to $29.6 million in 2022, then increased by 10.02% to $32.5 million in 2023, then grew by 8.31% to $35.2 million in 2024.
• The last three Shares Outstanding (Diluted Average) figures came in at $35.2 million (Q3 2024), $35.0 million (Q2 2024), and $34.7 million (Q1 2024), per Business Quant data.